In the largest forum of its kind, more than 4,000 doctors, scientists and caregivers from around the world are meeting today in Atlanta for the 28th annual North American Cystic Fibrosis Conference (NACFC).

Sponsored by the Cystic Fibrosis Foundation, NACFC offers attendees a unique opportunity to share information on recent progress in CF drug development, research and care.

“This year marks the 25th anniversary of the discovery of the CF gene,” said Robert J. Beall, Ph.D., president and CEO of the CF Foundation. “Since that pivotal milestone, we have made tremendous advances in the science and treatment of cystic fibrosis. NACFC brings together talented and dedicated individuals from a wide array of disciplines who collaborate year-round to find a cure.”

From Oct. 9 through Oct. 11, NACFC attendees will explore such topics as:

• Progress of clinical research targeting the underlying cause of CF
• Advances in understanding CF microbiology and treating lung infections
• Harnessing the power of biomedical research to design a CF care model fit for the future
• Novel approaches and technologies to address all CF gene mutations
• Best practices in CF clinical care at every stage of life

Portions of the scientific conference will also be streamed live online for the CF community, including the conference's three plenary presentations and select sessions. The Foundation will also stream a live conversation between an adult with CF and Michael P. Boyle, M.D., FCCP, director of the adult program at Johns Hopkins Cystic Fibrosis Center.

For updates from NACFC, follow us on Twitter.